| Drug Type Synthetic peptide | 
| Synonyms HYFT 71216b, HYFT71216b | 
| Target | 
| Action agonists | 
| Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseDiscovery | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Metabolic Diseases | Discovery | United States  | 01 Mar 2025 | |
| Metabolic Diseases | Discovery | Belgium  | 01 Mar 2025 | 






